Introcan Safety
Payments companies reported to CMS as associated with Introcan Safety. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Introcan Safety, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Introcan Safety
These are the largest totals companies reported as associated with Introcan Safety. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Pickett | Houston, TX | Pediatrics (Nurse Practitioner) | $13,785.46 |
| John Ledonne | Baltimore, MD | Surgery | $10,379.57 |
| Obinna Uzodinma | Dallas, TX | Anesthesiology | $8,014.05 |
| Kimmerle Pawar | Boca Raton, FL | Emergency Medicine | $4,716.69 |
| John Winchester | San Francisco, CA | Anesthesiology | $1,400.00 |
| Robert Helm | Portsmouth, NH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $241.99 |
| Lauren Daman | Hartford, CT | Dermatology | $223.29 |
| April Winborne | Winnsboro, LA | Family | $223.29 |
| Matthew Ostroff | Paterson, NJ | Acute Care (Nurse Practitioner) | $223.29 |
| Amit Bahl | Royal Oak, MI | Emergency Medicine | $171.82 |
Prescribed Introcan Safety?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.